Uesaka K., Boku N, Fukutomi A, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomized, non-inferiority trial (JASPAC 01). Lancet 2016 ; 388 : 248-57.
Sadeghi N, Abbruzzese JL, Yeung SC, et al. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 2012 ; 18 : 2905-12.
Carlsen SM, Grill V, Følling I. Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease. Diabetes Res Clin Pract 1998 ; 39 ; 47-54.
Motoi F, Kosuge T, Ueno H, et al. Randomized phase II/III trial of neoadjyuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05). Jpn J Clin Oncol 2019 ; 49 : 190-4.